Amrutanjan Health Care Intrinsic Value
Amrutanjan Health Care (AMRUTANJAN) median intrinsic value is ₹950.83 from 2 valuation models (range ₹727–₹951), vs current price ₹559.95 — +69.8% upside (Trading Below Calculated Value), margin of safety 41.1%. For current market price and key ratios, visit Amrutanjan Health Care share price screener.
AMRUTANJAN Valuation Methods Summary — DCF, Graham Number & P/E
Amrutanjan Health Care intrinsic value across 2 models vs current price ₹559.95 — upside/downside and value range per method. Browse AMRUTANJAN financial statements for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹726.67 | ₹654.00 - ₹799.34 | +29.8% | Book Value/Share: ₹363.33, P/B: 2.0x |
| Simple DCF (5Y) | dcf | ₹950.83 | ₹760.66 - ₹1141.00 | +69.8% | CF Growth: 15.0%, Discount: 15% |
AMRUTANJAN Intrinsic Value vs Market Price — All Valuation Models
Amrutanjan Health Care fair value range ₹727–₹951 vs current market price ₹559.95 across 2 valuation models. Also explore Amrutanjan Health Care share price performance to track price trends across different timeframes.
AMRUTANJAN Intrinsic Value Analysis — Undervalued or Overvalued?
Amrutanjan Health Care median intrinsic value ₹950.83, current price ₹559.95 — Trading Below Calculated Value by 69.8%, margin of safety 41.1%.
What is the intrinsic value of AMRUTANJAN?
Based on our comprehensive analysis using 2 different valuation methods, the estimated intrinsic value of Amrutanjan Health Care (AMRUTANJAN) is ₹950.83 (median value). With the current market price of ₹559.95, this represents a +69.8% variance from our estimated fair value.
The valuation range spans from ₹726.67 to ₹950.83, indicating ₹726.67 - ₹950.83.
Is AMRUTANJAN undervalued or overvalued?
Based on our multi-method analysis, Amrutanjan Health Care (AMRUTANJAN) appears to be trading below calculated value by approximately 69.8%.
AMRUTANJAN Financial Health — Key Ratios vs Industry Benchmarks
Amrutanjan Health Care financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 25.25 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
AMRUTANJAN Cash Flow Quality — Operating & Free Cash Flow
Amrutanjan Health Care operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2016 | ₹21 Cr | ₹21 Cr | Positive Free Cash Flow | 8/10 |
| March 2015 | ₹18 Cr | ₹16 Cr | Positive Free Cash Flow | 8/10 |